ALTURA PHARMACEUTICALS
DEAD

Serial Number

78949007

Owner

Guirado, Rafael

First Use Date

Jan 15, 2006

Filing Date

Aug 9, 2006

Add to watchlist:

No watchlists yet
View on USPTO

ALTURA PHARMACEUTICALS Trademark

Serial Number: 78949007

ALTURA PHARMACEUTICALS is a trademark filed by Guirado, Rafael on August 9, 2006. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Guirado, Rafael

12540 McCann Drive
Santa Fe Springs, CA 90670

Entity Type: 01

Trademark Details

Filing Date

August 9, 2006

Registration Date

Not Registered

First Use Anywhere

January 15, 2006

First Use in Commerce

January 15, 2006

Goods & Services

Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Astringents ; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely, anticoagulants; Pharmaceutical preparations namely,antidepressants; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Sep 14, 2008 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Sep 14, 2008 WOAR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 12, 2007 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 12, 2007 ABN2
ASSIGNED TO EXAMINER
Sep 5, 2007 DOCK
ASSIGNED TO EXAMINER
Aug 16, 2007 DOCK
NON-FINAL ACTION E-MAILED
Jan 9, 2007 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2007 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2007 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 8, 2006 TCCA
NEW APPLICATION ENTERED
Aug 16, 2006 NWAP